<DOC>
	<DOC>NCT00696826</DOC>
	<brief_summary>A study to compare the plasma concentrations of MK0431 at different times in patients with hepatic insufficiency vs healthy control subjects.</brief_summary>
	<brief_title>A Study of MK0431 in Patients WIth Hepatic Insufficiency (0431-017)(COMPLETED)</brief_title>
	<detailed_description />
	<mesh_term>Hepatic Insufficiency</mesh_term>
	<mesh_term>Sitagliptin Phosphate</mesh_term>
	<criteria>If female, non pregnant, BMI less than 40 kg/m2 Patient has chronic, stable hepatic insufficiency Patient unwilling to refrain from alcohol and grapefruit juice prior to and shortly after study drug administration Patient has diabetes, had a heart attack or stroke, or uncontrolled congestive heart failure during the past 6 months Patient has a history of drug or alcohol abuse Patient smokes &gt; 10 cigarettes per day Patient consumes more that 6 cups of caffeinated beverages per day Patient has had surgery, donated blood or participated in another clinical trial within the past 4 weeks</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>August 2015</verification_date>
</DOC>